mecamylamine has been researched along with Abnormalities, Congenital in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ROWE, GG | 1 |
| CASTILLO, CA | 1 |
| MAXWELL, GM | 1 |
| FREEMAN, DJ | 1 |
| WHITE, DH | 1 |
| CRUMPTON, CW | 1 |
1 other study available for mecamylamine and Abnormalities, Congenital
| Article | Year |
|---|---|
The effect of mecamylamine on coronary flow, cardiac work, and cardiac efficiency in normotensive dogs.
Topics: Animals; Autonomic Agents; Autonomic Nervous System; Blood Pressure; Congenital Abnormalities; Coron | 1958 |